Biliary tact carcinoids are extremely rare: only ten cases have been reported up to now. The Authors describe a successfully treated carcinoid tumour ofthe proximal bile duct and review the literature about these rare malignancies.
INTRODUCTION
Carcinoid tumours (argentaffinoma) may occur anywhere in the distribution of the argentaffin cell system. They are derived from Kultschizky cells and have the potential to produce serotonin. Cases occurring in the bladder, prostate, rectum, stomach, bronchi, pancreas and biliary tract have been reported, in addition to the more common sites in the ileum and appendix1.
Biliary tract carcinoids are exceedingly rare. Jutte and coworkers in 1986 surveyed the world literature and found 23 cases, seventeen arising in the gallbladder and seven in the extrahepatic bile ducts2. Since then there appears to have been only two further reported cases, to our knowledge 3,4. In this paper we describe a successfully treated carcinoid tumour of the proximal common bile duct and review the literature about these rare malignancies. (Figure 1 ). Laparotomy was performed through a right subcostal incision. The gallbladder was removed. A 1.5 rubber-like mass was encasing the common bile duct. Biliary system was divided immediately above the duodenum and its lower part was dissected from the underlying portal vein and hepatic artery together with the associated connective tissue and lymphnodes. Then the biliary duct was transected at the hilum junction, the specimen removed and a Roux-en-Y hepaticoJejunostomy performed.
Postoperative course was uneventful." bilirubin levels fell to 7.7 mg/dl on the fourth postoperative day and the patient was discharged on the twelveth postoperative day.
The patient remains well 15 months after surgery with normal bilirubin levels (0.9 mg/dl) and no clinical or radiological signs of recurrent disease or meta- stases 3 and one by resection of the common bile duct with a Roux-en-Y hepaticojejunostomy . Our patient underwent a common hepatic duct resection followed by a Roux-en-Y hepatico-jejunostomy at the hilum junction, due to the high biliary location of the tumour.
As for adjuvant treatment, radiotherapy is generally considered of little benefit in the management of carcinoids, whereas chemotherapy with 5-FU has proved to be of some palliative value in carcinoids of other sites2.
Considering the non-aggressive behaviour and the slow-growing nature of these malignancies, major surgery is reasonable and fully justified, whenever possible, particularly in fit patients. Biliary continuity should then be restored by biliodigestive anastomoses.
